F Raue
Overview
Explore the profile of F Raue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
212
Citations
1817
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scherubl H, Raue F, Frank-Raue K
Radiologe
. 2019 Jul;
59(11):952-960.
PMID: 31359091
Context: Neuroendocrine tumors (NET) are a heterogeneous group of neoplasms found in all organs. They often present with characteristic clinical syndromes due to hormone hypersecretion. Diagnostics: In addition to hormone...
2.
Mucha L, Leidig-Bruckner G, Frank-Raue K, Bruckner T, Kroiss M, Raue F
Clin Endocrinol (Oxf)
. 2017 Jun;
87(4):320-326.
PMID: 28605116
Objectives: We describe phaeochromocytoma (phaeo) penetrance in multiple endocrine neoplasia type 2 (MEN2) according to RET protooncogene-specific mutations and report changes in phaeo diagnosis and management from 1968 to 2015....
3.
Cordes M, Kuwert T, Haag C, Raue F
Horm Metab Res
. 2016 Dec;
49(2):142-146.
PMID: 27926951
Familial hypocalciuric hypercalcemia (FHH) belongs to the disorders of a disturbed calcium homeostasis. Genetically, the disorder is inherited in an autosomal-dominant trait and represents an inactivating mutation of the calcium...
4.
Leidig-Bruckner G, Bruckner T, Raue F, Frank-Raue K
Horm Metab Res
. 2016 Nov;
48(12):806-813.
PMID: 27813050
This study aimed to identify factors influencing long-term outcome in complete or partial postoperative hypoparathyroidism (parathyroid hormone ≤10 or >10 ng/l, respectively) in medullary thyroid carcinoma (MTC). It was designed...
5.
Raue F, Wilhelm T
Radiologe
. 2014 Sep;
54(10):975-80.
PMID: 25223437
Clinical Issue: Multiple endocrine neoplasia (MEN) types 1 and 2 are hereditary cancer syndromes. They are characterized by the occurrence of many benign and malignant tumor types. Standard Treatment: Carriers...
6.
Leidig-Bruckner G, Raue F, Frank-Raue K
Dtsch Med Wochenschr
. 2012 Feb;
137(7):326-32.
PMID: 22318848
Osteoporosis is a systemic skeletal disease causing increased fracture risk. According to pathogenesis, primary (70 - 80 %) and secondary osteoporosis (20 - 30 %) are distinguished. Secondary osteoporosis comprises...
7.
Frank-Raue K, Leidig-Bruckner G, Lorenz A, Rondot S, Haag C, Schulze E, et al.
Dtsch Med Wochenschr
. 2011 Sep;
136(38):1889-94.
PMID: 21915802
Objective: The challenge in diagnosing primary hyperparathyroidism (HPT) is to detect hereditary cases before first surgery. About 5% of cases are hereditary and integral component of multiple endocrine neoplasia type...
8.
Frank-Raue K, Ganten M, Kreissl M, Raue F
Exp Clin Endocrinol Diabetes
. 2010 Sep;
119(3):151-5.
PMID: 20827665
Objective: To investigate the efficacy of sorafenib in progressive metastatic Medullary Thyroid Carcinoma (MTC), for which there is currently no effective treatment. Design: Off-label observational study. Methods: Sorafenib 400 mg...
9.
Leidig-Bruckner G, Roth H, Bruckner T, Lorenz A, Raue F, Frank-Raue K
Osteoporos Int
. 2010 Jun;
22(1):231-40.
PMID: 20556359
Unlabelled: Vitamin D deficiency is associated with increased fracture risk. The observational study aimed to investigate vitamin D status and supplementation in ambulatory patients. Only 20% of patients had optimal...
10.
Frank-Raue K, Dohring J, Scheumann G, Rondot S, Lorenz A, Schulze E, et al.
Exp Clin Endocrinol Diabetes
. 2009 Dec;
118(8):550-3.
PMID: 20013610
Unlabelled: Clinical studies are needed to classify rare and novel RET mutations associated with hereditary medullary thyroid carcinoma (MTC) into one of the clinical risk groups. Here we describe two...